November 22, 2017 10:16 AM ET


Company Overview of BioAmber Inc.

Executive Profile

Kurt W. Briner

Independent Director, BioAmber Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Member in 1 organization across 4 different industries.

See Board Relationships


Mr. Kurt W. Briner served as President and Chief Executive Officer of Sanofi Pharma S.A. in Geneva, Switzerland from 1988 to 2000. Mr. Briner has nearly 31 years of experience in the pharmaceutical industry. He served as the Chairman at BioAmber Inc. from 2009 to February 2012 and has been its Independent Director since 2009. He served as a Director of Galenica Ltd. since 2004 until May 8, 2014. He serves as a Director of Novo Nordisk Danmark and Altana Pharma. He served ...

Corporate Headquarters

1250 Rene Levesque West
Montreal, Quebec H3B 4W8


Phone: 514-844-8000
Fax: 514-844-1414

Board Members Memberships

Independent Director


There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$62,500
Total Calculated Compensation$116,359

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Charles E. Coppa CEO, CFO, Treasurer & Secretary
American Power Group Corporation
Brian Kletscher Chief Executive Officer
Highwater Ethanol, LLC
Tai-Ming Ou Co-Founder, Chairman, Chief Executive Officer and President
China Clean Energy Inc.
R. Samuel Bell Jr.Chief Executive Officer & Chairman
Incoming, Inc.
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BioAmber Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at